Skip to content

Magnetomotoric Ultrasound (MMUS) in Rectal Cancer

Magnetomotoric Ultrasound (MMUS) in the Staging of Rectal Cancer

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05052086
Acronym
MAMORECT
Enrollment
60
Registered
2021-09-22
Start date
2022-11-01
Completion date
2025-01-01
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Brief summary

Magnetomotoric ultrasound, combines conventional ultrasound with a time-varying magnetic field. The aim is to improve diagnosis of mesolectal lymph nodes.

Detailed description

Magnetomotoric ultrasound, combines conventional ultrasound with a time-varying magnetic field. Nanoparticles are injected close to the rectal cancer and migrate to adjacent lymph nodes.The time-varying magnetic field will influence the nano particles in the lymph node enhancing diagnosis of affected lymph nodes. The aim is to improve diagnosis of mesolectal lymph nodes and compare the results of magnetomotoric ultrasound with MRI and final histopathology.

Interventions

DIAGNOSTIC_TESTMagnetomotoric ultrasound

Nanoparticles will be injected close to the tumor. Magnetomotoric ultrasound will be performed just before scheduled standard operation, when the patient is anesthetized.

Sponsors

Region Skane
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Included patients will undergo magnetomotoric ultrasound in addition to conventional MRI. The results of MRI examination and magnetomotoric ultrasound will be compared with final histopathology.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Rectal cancer * Scheduled for total mesorectal surgery * Informed consent

Exclusion criteria

* Not able to give informed consent * Synchronus colorectal cancer

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of mesorectal lymph node diagnosis with MMUS, compared with final histopathologyApproximately 1 hour after MMUSEvaluation of the accuracy of MMUS in detecting lymph node metastases in rectal cancer. The results of the MMUS (malignant or benign lymph nodes) will be compared with final histopathology. The accuracy will be expressed in sensitivity (%), specificity (%) and overall accuracy (% correctly staged lymph nodes with MMUS)
Accuracy of mesorectal lymph node diagnosis with MMUS, compared with preoperative MRIApproximately 1 hour after MMUSEvaluation of the accuracy of MMUS in detecting lymph node metastases in rectal cancer in comparison to standard staging (MRI). The results of the MMUS (malignant nodes or benign nodes) will be compared with the results of preoperative MRI (malignant or benign lymph nodes) and the final histopathology. The accuracy will be expressed in sensitivity (%), specificity (%) and overall accuracy (% correctly staged lymph nodes) with MMUS and MRI.

Countries

Sweden

Contacts

Primary ContactCarl-Fredrik Rönnow, MD, PhD
carl-fredrik.ronnow@med.lu.se+4640-331635
Backup ContactHenrik Thorlacius, Professor
henrik.thorlacius@med.lu.se+46 40-331000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026